Recombinant batroxobin (Sinobiomed)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant batroxobin (Sinobiomed)
Drug Alias NamerBAT (Sinobiomed)重组巴曲酶（Sinobiomed）
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionFibrinogen inhibitors
TargetsFibrinogen
Therapy Area/IndicationsBlood Loss, Surgical
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSinobiomed
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSinobiomed
Active IndicationsN/A
Inactive IndicationsBlood Loss, Surgical

Other Information

ATC CodeN/A
Related LinksN/A